Skip to main content

Advertisement

Table 1 Participant characteristics

From: Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy

  MPH (n = 16) ATX (n = 14) p value
Mean SD Mean SD
Sex (male/female)a 14/2   11/3   0.642
Age (years) 8.19 2.46 9.50 2.03 0.125
Medication dose (mg/kg) 0.87 0.23 1.30 0.44 NA
FIQ (WISC-IV) 94.19 13.46 96.64 14.43 0.634
ARF 30.63 10.65 32.29 13.46 0.709
ARI 16.75 5.52 18.29 6.84 0.502
ARH 13.88 6.72 14.00 7.99 0.963
SCWC-1 18.31 7.66 25.86 8.76 0.018
SCWC-2 19.81 9.56 29.36 11.11 0.017
SCWC-3 21.19 9.17 25.36 10.35 0.252
  1. MPH methylphenidate, ATX atomoxetine, NA not applicable, FIQ full-scale IQ, WISC-IV Wechsler Intelligence Scale for children-fourth edition, ARF ADHD RS IV-J full scores, ARI ADHD RS IV-J inattention subscale scores, ARH ADHD RS IV-J hyperactivity subscale scores, SCWC-1 Stroop color-word task number of correct answers first time, SCWC-2 Stroop color-word task number of correct answers second time, SCWC-3 Stroop color-word task number of correct answers third time
  2. aThe Chi square test was used; otherwise t-tests were used